SEC Form 4 · accession 0001179110-18-012262
Natera, Inc. · NTRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jonathan Sheena
Officer — Chief Technology Officer · Director
Period of report
Oct 15, 2018
Accepted (ET)
Oct 17, 2018 · 7:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001604821
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 15, 2018 | M | 25,491 | $1.141 | A | 372,583 | D | |
| Common Stock | Oct 15, 2018 | M | 8,233 | $2.6569 | A | 380,816 | D | |
| Common StockF2 | Oct 15, 2018 | S | 33,724 | $20.2666 | D | 347,092 | D | |
| Common StockF3 | Oct 15, 2018 | S | 50,672 | $20.2882 | D | 296,420 | D | |
| Common Stock | Oct 16, 2018 | M | 16,276 | $1.141 | A | 312,696 | D | |
| Common StockF6 | Oct 16, 2018 | S | 7,100 | $20.6233 | D | 305,596 | D | |
| Common StockF7 | Oct 16, 2018 | S | 9,176 | $21.2194 | D | 296,420 | D | |
| Common StocjF8 | Oct 16, 2018 | S | 11,791 | $20.5347 | D | 284,629 | D | |
| Common StockF9 | Oct 16, 2018 | S | 54,204 | $21.2015 | D | 230,425 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F10,F4 | $1.141 | Oct 15, 2018 | M | 25,491 | D | — | Sep 19, 2022 | Common Stock | 25,491 | 16,276 | D |
| Stock Option (right to buy)F5 | $2.6569 | Oct 15, 2018 | M | 8,233 | D | — | Feb 25, 2024 | Common Stock | 8,233 | 537,481 | D |
| Stock Option (right to buy)F4 | $1.141 | Oct 16, 2018 | M | 16,276 | D | — | Sep 19, 2022 | Common Stock | 16,276 | 0 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2018.
- F10The Form 4 filed on November 25, 2016 ("Prior Filing") reflects an exercise of a stock option for 25,895 shares. The Prior Filing inadvertently included the exercise of 2,413 shares from a separate option granted to the Reporting Person on the same date understating the total amount beneficially owned following the reported transaction by 2,413 shares. The aggregate number of shares exercised on November 22, 2016 is correct as shown in Column 5. Prior to the transactions reported on this Form 4 the Reporting Person had a total of 41,767 shares remaining to exercise under the stock option.
- F2The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.92 to $20.64 per share, inclusive. The holder undertakesto provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.91 to $20.64 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4The option shares vest fully and became exercisable on July 8, 2015.
- F5The option shares vest fully and became exercisable on February 25, 2014.
- F6The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.07 to $21.06 per share, inclusive. The holder undertakesto provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F7The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.07 to $21.36 per share, inclusive. The holder undertakesto provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F8The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.99 per share, inclusive. The holder undertakesto provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F9The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.41 per share, inclusive. The holder undertakesto provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.